Skip to main content
GL logo

GL

Globe Life Inc.
$179.13 +0.27 (+0.15%) At close · Jul 10
Market Cap
$13.91B
Shares
77,644,761

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$179.13 Open$178.86 Day$176.64–179.54 52W$116.28–182.32 Avg vol 30d619K Short int1.7M · 2.1% float · 2.0d Short vol65% Last earningsApr 22, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 7
Up next
Next earnings call
Jul 19, 2026 Est · unconfirmed · in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 7, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Strong Buy
      SellHoldBuy
      Technical Neutral Momentum Very Strong Sentiment Bullish Fundamentals Strong Quant / Vol Very Low
      Market backdrop VIX 15 · calm Equity put/call 0.55
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +23%
      above
      Price vs 50-day avg +10%
      above
      RSI (14) 71
      overbought
      MACD trend Negative
      52-week position 95%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +10%
      trailing
      6-month return +28%
      trailing
      YTD return +28%
      this year
      Relative strength +19%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $163 › 200d $146 — 50d above 200d
      Institutional flow Accumulating
      37 of 664 funds reported for Jun 30 · net +12.7K sh shares · +4 new
      Insider flow Distributing
      Net -$30.8M over 90 days · 100% sells
      Short interest Falling
      2.13% of float · ▼ -10.3% MoM · 2.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      664 holders — near 3-yr high, broad support
      Squeeze score 52
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +4%
      Y/Y
      Gross margin 21%
      expanding
      EPS growth +18%
      Y/Y
      Free cash flow $1.3B
      Valuation P/E 12.4
      below peers
      Balance sheet $1.6B
      net debt
      Quant / Vol
      risk profile
      Very Low
      Volatility 21%
      annualized · 1-yr
      Max drawdown −11%
      past year
      ATR 1.9%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record
      Latest guidance · from the Earnings Call filed Mar 31, 2026
      full year
      Life premium revenue Initiated 3% – 3.5%
      Health premium revenue Initiated 14% – 17%
      Health underwriting margin Initiated 23% – 27%
      Administrative expenses Initiated 7.3%
      full year 2026
      Life underwriting margin Initiated 42% – 45%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 2 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +23% Bullish
      Price vs 50-day avg
      +10% Bullish
      RSI (14)
      71 Bearish
      MACD trend
      Negative Bearish
      52-week position
      95% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $163 › 200d $146 — 50d above 200d
      Institutional flow Accumulating
      37 of 664 funds reported for Jun 30 · net +12.7K sh shares · +4 new
      Insider flow Distributing
      Net -$30.8M over 90 days · 100% sells
      Short interest Falling
      2.13% of float · ▼ -10.3% MoM · 2.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      664 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $116 Now $179 · 95% 52-wk high $182
      vs 200-day avg +23% vs 50-day avg +10%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Health net sales (United American Division) $62M the year-ago quarter
      administrative expenses as percent of premium 7.4% Q1 call
      average producing agent count at American Income 11,064 Q1 call
      average producing agent count at Family Heritage 1,561 Q1 call
      average producing agent count at Liberty National 4,031 Q1 call
      average yield on fixed maturity investments 6.23% Q1 call
      book value per share excluding AOCI non-GAAP $98.56 as of March 31 call
      earned yield on total long-term invested assets 5.5% Q1 call
      excess investment income non-GAAP 37M Q1 call
      health underwriting margin 95M Q1 call
      health underwriting margin as percent of premium 23% Q1 call
      life underwriting margin 349M Q1 call
      life underwriting margin as percent of premium 41% Q1 call
      net operating income per share non-GAAP $3.43 Q1 call
      return on equity excluding AOCI non-GAAP 14% through March 31 call

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Insurance - Life — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      GL
      Globe Life Inc.
      this stock
      $13.91B +28.3% +3.7% 12.4 2.1%
      CILJF
      China Life Insurance Co Ltd
      $100.90B +3.5% 0.0%
      MFC
      Manulife Financial Corp
      $68.78B +14.9% 0.4%
      AFL
      Aflac Inc
      $62.05B +11.1% -9.3% 13.9 2.5%
      MET
      Metlife Inc
      $58.97B +16.9% +8.6% 17.7 2.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      667
      % held
      82.9%
      Reported
      37 of 664
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      526
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      1.7M
      Days to cover
      2.0d
      Change
      -191.1K sh
      View
      Short Volume
      Short vol %
      65%
      As of
      Jul 10, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      77.4K
      Value
      $12.8M
      As of
      Jun 12, 2026
      View
      Off-Exchange
      Off-exchange %
      36.4%
      Week of
      Jun 15, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$30.8M
      Buyers / Sellers
      0 / 9
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Lisa McClain
      Amount
      $1.0K–$15.0K
      Traded
      Jul 10, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $6.0B
      Net income (FY)
      $1.2B
      EPS diluted
      $14.07
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 29, 2026
      This year
      8
      View
      Proposed Sales
      Value
      $331.7K
      Shares
      1.9K
      Filed
      Jun 30, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Apr 22, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      GL -0.8% +10.2% +28.1% +0.3% +28.3%
      SPY +1.4% +4.1% +9.1% +1.1% +10.7%
      vs SPY -2.1% +6.2% +19.1% -0.9% +17.6%

      Capital returns

      Latest dividend
      $0.33 / share · ex Jul 6, 2026
      Raised 22.2%
      Paid (TTM)
      $1.20 / share · 4 payouts
      Dividend yield (TTM, derived)
      0.67%

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 320335 CUSIP 37959E102 13F (30d) 63 filings 41 filers Visit website Investor relations